Over the past few years, increasing evidence has revealed that the pan-carcinoma-associated Thomsen-Friedenreich (TF) antigen is a natural ligand of the galactoside-binding galectins and the oncofetal TF-galectin interaction influences a number of key steps in cancer progression and metastasis [127]. The gene discussed is TF; the disease is cancer.